AVP-923
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for AVP-923, covering 2015-07-13 to 2022-04-29. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients [Phase 2]